Head-to-head · WeighScore
InstaRX vs Midi Health
The verdict
InstaRX takes it — 63.8/100 to 56.4/100.
InstaRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. InstaRX is a multi-product compounded-medication telehealth platform offering GLP-1 injections (semaglutide and tirzepatide) alongside anti-aging peptides (NAD+, Sermorelin, B12/MIC) and sexual-health…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | InstaRX | Midi Health |
|---|---|---|
| WeighScore | 63.8/100 | 56.4/100 |
| Grade | C | C |
| Scorecard rank | #250 | #413 |
| Semaglutide | $199/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $199/mo (starting dose, compounded) | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #250 · C
Strengths
- Available in all 50 states plus DC
- Manage GLP-1, anti-aging peptides, and sexual-health medications on one account
- Offers both compounded semaglutide and compounded tirzepatide
- Independent provider group (Dr Telx) named in the Terms of Service
Where it loses points
- No per-dose or monthly pricing published — only a "$199 to get started" hook; you can't compare costs before intake
- No LegitScript, HIPAA, or NABP accreditation shown on public pages
- Compounding pharmacy not named — only "U.S. pharmacies"
- Terms of Service reads like generic boilerplate, including copy-paste language about women's health issues — suggests low template hygiene
- Delaware governing law for disputes despite a California corporate address
Graded #413 · C
Strengths
- Available in all 50 states
- Accepts commercial insurance — a differentiator vs cash-pay-only GLP-1 telehealth
- Menopause + metabolic-health focus suits women where GLP-1 efficacy and weight regulation overlap most
- Transparent self-pay visit fees ($250 initial, $150 follow-up); GLP-1 can also be billed through commercial insurance (copay + deductible)
Where it loses points
- Does not accept Medicare, Medicaid, or Medi-Cal
- GLP-1 is prescribed at clinician discretion within a menopause plan, not guaranteed at intake
- Menopause-focused — not the right fit for men or younger women whose main goal is weight loss
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.